637
Views
5
CrossRef citations to date
0
Altmetric
REVIEW

What Dietary Patterns and Nutrients are Associated with Pancreatic Cancer? Literature Review

ORCID Icon, & ORCID Icon
Pages 17-30 | Received 17 Sep 2022, Accepted 23 Dec 2022, Published online: 06 Jan 2023

References

  • Global cancer observatory; 2020. Available from: https://gco.iarc.fr/. Accessed February 10, 2022.
  • Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018;24(19):2047. doi:10.3748/wjg.v24.i19.2047
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Khalaf N, El-Serag HB, Abrams HR, et al. Burden of pancreatic cancer: from epidemiology to practice. Clin Gastroenterol Hepatol. 2021;19(5):876–884. doi:10.1016/j.cgh.2020.02.054
  • Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63. doi:10.14740/wjon1191
  • Zheng J, Guinter MA, Merchant AT, et al. Dietary patterns and risk of pancreatic cancer: a systematic review. Nutr Rev. 2017;75(11):883–908. doi:10.1093/nutrit/nux038
  • Petrick JL, Castro-Webb N, Gerlovin H, et al. A prospective analysis of intake of red and processed meat in relation to pancreatic cancer among African American women. Cancer Epidemiol Prev Biomarkers. 2020;29(9):1775–1783. doi:10.1158/1055-9965.EPI-20-0048
  • Zhao Z, Yin Z, Pu Z, et al. Association between consumption of red and processed meat and pancreatic cancer risk: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(4):486–93. e10. doi:10.1016/j.cgh.2016.09.143
  • Yamagiwa Y, Sawada N, Shimazu T, et al. Fruit and vegetable intake and pancreatic cancer risk in a population-based cohort study in Japan. Int J Cancer. 2019;144(8):1858–1866. doi:10.1002/ijc.31894
  • Zhao Z, Yu P, Feng X, et al. No associations between fruit and vegetable consumption and pancreatic cancer risk: a meta-analysis of prospective studies. Oncotarget. 2018;9(63):32250. doi:10.18632/oncotarget.23128
  • Alizadeh S, Shab-Bidar S, Mohtavinejad N, et al. A posteriori dietary patterns and risk of pancreatic and renal cancers. Nutr Food Sci. 2017;47:839–868. doi:10.1108/NFS-03-2017-0053
  • Clinton SK, Giovannucci EL, Hursting SD. The World Cancer Research Fund/American Institute for Cancer Research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr. 2020;150(4):663–671. doi:10.1093/jn/nxz268
  • Bravi F, Polesel J, Bosetti C, et al. Dietary intake of selected micronutrients and the risk of pancreatic cancer: an Italian case–control study. Ann Oncol. 2011;22(1):202–206. doi:10.1093/annonc/mdq302
  • Han X, Li J, Brasky TM, et al. Antioxidant intake and pancreatic cancer risk: the Vitamins and Lifestyle (VITAL) study. Cancer. 2013;119(7):1314–1320. doi:10.1002/cncr.27936
  • Liu Y, Wang X, Sun X, et al. Vitamin intake and pancreatic cancer risk reduction: a meta-analysis of observational studies. Medicine. 2018;97(13):115.
  • Nucci D, Santangelo OE, Provenzano S, et al. Dietary fiber intake and risk of pancreatic cancer: systematic review and meta-analysis of observational studies. Int J Environ Res Public Health. 2021;18(21):11556. doi:10.3390/ijerph182111556
  • Wang J, Wang W-J, Zhai L, et al. Association of cholesterol with risk of pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21(12):3711. doi:10.3748/wjg.v21.i12.3711
  • Nöthlings U, Murphy SP, Wilkens LR, et al. A food pattern that is predictive of flavonol intake and risk of pancreatic cancer. Am J Clin Nutr. 2008;88(6):1653–1662. doi:10.3945/ajcn.2008.26398
  • Arem H, Bobe G, Sampson J, et al. Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP diet and health study cohort. Br J Cancer. 2013;108(5):1168–1172. doi:10.1038/bjc.2012.584
  • Inoue-Choi M, Flood A, Robien K, et al. Nutrients, food groups, dietary patterns and risk of pancreatic cancer in postmenopausal women. Cancer Epidemiol Prev Biomarkers. 2011;20:711–714. doi:10.1158/1055-9965.EPI-11-0026
  • Jiao L, Flood A, Subar AF, et al. Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study. Cancer Epidemiol Prev Biomarkers. 2009;18(4):1144–1151. doi:10.1158/1055-9965.EPI-08-1135
  • Aune D, Chan D, Vieira A, et al. Dietary fructose, carbohydrates, glycemic indices and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol. 2012;23(10):2536–2546. doi:10.1093/annonc/mds076
  • Johnson KJ, Anderson KE, Harnack L, et al. No association between dietary glycemic index or load and pancreatic cancer incidence in postmenopausal women. Cancer Epidemiol Prev Biomarkers. 2005;14(6):1574–1575. doi:10.1158/1055-9965.EPI-05-0138
  • Silvera SA, Rohan TE, Jain M, et al. Glycemic index, glycemic load, and pancreatic cancer risk (Canada). Cancer Causes Control. 2005;16(4):431–436. doi:10.1007/s10552-004-5028-7
  • Tseng T-S, Lin H-Y, Griffiths L, et al. Sugar intake from sugar-sweetened beverage among cancer and non-cancer individuals: the NHANES study. Transl Cancer Res. 2016;5(5):1019–1028. doi:10.21037/tcr.2016.09.42
  • Wang F, Herrington M, Larsson J, et al. The relationship between diabetes and pancreatic cancer. Mol Cancer. 2003;2(1):1–5. doi:10.1186/1476-4598-2-4
  • Meinhold CL, Dodd KW, Jiao L, et al. Available carbohydrates, glycemic load, and pancreatic cancer: is there a link? Am J Epidemiol. 2010;171(11):1174–1182. doi:10.1093/aje/kwq061
  • Michaud DS, Liu S, Giovannucci E, et al. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst. 2002;94(17):1293–1300. doi:10.1093/jnci/94.17.1293
  • Genkinger JM, Li R, Spiegelman D, et al. Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Prev Biomarkers. 2012;21(2):305–318. doi:10.1158/1055-9965.EPI-11-0945-T
  • Mueller NT, Odegaard A, Anderson K, et al. Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study. Cancer Epidemiol Prev Biomarkers. 2010;19(2):447–455. doi:10.1158/1055-9965.EPI-09-0862
  • Nöthlings U, Murphy SP, Wilkens LR, et al. Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Am J Clin Nutr. 2007;86(5):1495–1501. doi:10.1093/ajcn/86.5.1495
  • Bidoli E, Pelucchi C, Zucchetto A, et al. Fiber intake and pancreatic cancer risk: a case–control study. Ann Oncol. 2012;23(1):264–268. doi:10.1093/annonc/mdr060
  • Zhang J, Dhakal IB, Gross MD, et al. Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota. Nutr Cancer. 2009;61(4):457–465. doi:10.1080/01635580902718941
  • La Vecchia C, Chatenoud L, Negri E, et al. Whole grain cereals and cancer in Italy. Proc Nutr Soc. 2003;62(1):45–49. doi:10.1079/PNS2002235
  • Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Prev Biomarkers. 2005;14(9):2093–2097. doi:10.1158/1055-9965.EPI-05-0226
  • Hallfrisch J, Behall KM. Mechanisms of the effects of grains on insulin and glucose responses. J Am Coll Nutr. 2000;19(sup3):320S–25S. doi:10.1080/07315724.2000.10718967
  • Jensen MK, Koh-Banerjee P, Franz M, et al. Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation. Am J Clin Nutr. 2006;83(2):275–283. doi:10.1093/ajcn/83.2.275
  • Garcia AL, Otto B, Reich SC, et al. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. Eur J Clin Nutr. 2007;61(3):334–341. doi:10.1038/sj.ejcn.1602525
  • Galisteo M, Duarte J, Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 2008;19(2):71–84. doi:10.1016/j.jnutbio.2007.02.009
  • Delzenne NM, Cani PD. A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care. 2005;8(6):636–640. doi:10.1097/01.mco.0000171124.06408.71
  • Benítez-Páez A, Pulgar EMG, Kjølbæk L, et al. Impact of Dietary Fiber and Fat on Gut Microbiota Re-Modeling and Metabolic Health. Elsevier; 2016.
  • Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, et al. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol. 2002;155(9):783–792. doi:10.1093/aje/155.9.783
  • Ghorbani Z, Pourshams A, Fazeltabar MA, et al. Major dietary protein sources in relation to pancreatic cancer: a large prospective study. 2016.
  • Ghadirian P, Nkondjock A. Consumption of food groups and the risk of pancreatic cancer: a case–control study. J Gastrointest Cancer. 2010;41(2):121–129. doi:10.1007/s12029-009-9127-2
  • Larsson S, Wolk A. Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer. 2012;106(3):603–607. doi:10.1038/bjc.2011.585
  • Rohrmann S, Linseisen J, Nöthlings U, et al. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2013;132(3):617–624. doi:10.1002/ijc.27637
  • Larsson SC, Håkanson N, Permert J, et al. Meat, fish, poultry and egg consumption in relation to risk of pancreatic cancer: a prospective study. Int J Cancer. 2006;118(11):2866–2870. doi:10.1002/ijc.21732
  • Qin B, Xun P, He K. Fish or long-chain (n-3) PUFA intake is not associated with pancreatic cancer risk in a meta-analysis and systematic review. J Nutr. 2012;142(6):1067–1073. doi:10.3945/jn.111.156711
  • Gao Y, Ma Y, Yu M, et al. Poultry and fish intake and pancreatic cancer risk: a systematic review and meta-analysis. Nutr Cancer. 2020;2020:1–13.
  • Gold EB, Gordis L, Diener MD, et al. Diet and other risk factors for cancer of the pancreas. Cancer. 1985;55(2):460–467. doi:10.1002/1097-0142(19850115)55:2<460::AID-CNCR2820550229>3.0.CO;2-V
  • Olsen GW, Mandel JS, Gibson RW, et al. A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. Am J Public Health. 1989;79(8):1016–1019. doi:10.2105/AJPH.79.8.1016
  • Raymond L, Infante F, Tuyns A, et al. Diet and cancer of the pancreas. Gastroenterol Clin Biol. 1987;11(6–7):488–492.
  • Bao Y, Hu F, Giovannucci E, et al. Nut consumption and risk of pancreatic cancer in women. Br J Cancer. 2013;109(11):2911–2916. doi:10.1038/bjc.2013.665
  • Appel M, Meijers M, Garderen-Hoetmer V, et al. Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats. Br J Cancer. 1992;66(1):46–50. doi:10.1038/bjc.1992.214
  • Ghadirian P, Lynch H, Krewski D. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev. 2003;27(2):87–93. doi:10.1016/S0361-090X(03)00002-3
  • Heinen MM, Verhage BA, Goldbohm RA, et al. Meat and fat intake and pancreatic cancer risk in the Netherlands Cohort Study. Int J Cancer. 2009;125(5):1118–1126. doi:10.1002/ijc.24387
  • Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20(2):197–209. doi:10.1016/j.bpg.2005.10.001
  • Jiao L, Chen L, White DL, et al. Low-fat dietary pattern and pancreatic cancer risk in the women’s health initiative dietary modification randomized controlled trial. J Natl Cancer Institute. 2018;110(1):49–56. doi:10.1093/jnci/djx117
  • Nöthlings U, Wilkens LR, Murphy SP, et al. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst. 2005;97(19):1458–1465. doi:10.1093/jnci/dji292
  • Thiébaut AC, Jiao L, Silverman DT, et al. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Institute. 2009;101(14):1001–1011. doi:10.1093/jnci/djp168
  • Nkondjock A, Krewski D, Johnson K, et al. Specific fatty acid intake and the risk of pancreatic cancer in Canada. Br J Cancer. 2005;92(5):971–977. doi:10.1038/sj.bjc.6602380
  • Ghamarzad Shishavan N, Masoudi S, Mohamadkhani A, et al. Dietary intake of fatty acids and risk of pancreatic cancer: golestan cohort study. Nutr J. 2021;20(1):1–14. doi:10.1186/s12937-021-00723-3
  • Liu J, Ma DW. The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancer. Nutrients. 2014;6(11):5184–5223. doi:10.3390/nu6115184
  • Strouch MJ, Ding Y, Salabat MR, et al. A high omega-3 fatty acid diet mitigates murine pancreatic precancer development. J Surg Res. 2011;165(1):75–81. doi:10.1016/j.jss.2009.04.022
  • Xu Y, Qian SY. Anti-cancer activities of ω-6 polyunsaturated fatty acids. Biomed J. 2014;37(3):112. doi:10.4103/2319-4170.131378
  • Chen H, Qin S, Wang M, et al. Association between cholesterol intake and pancreatic cancer risk: evidence from a meta-analysis. Sci Rep. 2015;5(1):1–6.
  • Ferretti G, Bacchetti T, Nègre-Salvayre A, et al. Structural modifications of HDL and functional consequences. Atherosclerosis. 2006;184(1):1–7. doi:10.1016/j.atherosclerosis.2005.08.008
  • Haddy N, Sass C, Droesch S, et al. IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis. 2003;170(2):277–283. doi:10.1016/S0021-9150(03)00287-9
  • Ji B-T, Chow W-H, Gridley G, et al. Dietary factors and the risk of pancreatic cancer: a case-control study in Shanghai China. Cancer Epidemiol Prev Biomarkers. 1995;4(8):885–893.
  • Chen Q, Espey MG, Krishna MC, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci. 2005;102(38):13604–13609. doi:10.1073/pnas.0506390102
  • Du J, Martin SM, Levine M, et al. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res. 2010;16(2):509–520. doi:10.1158/1078-0432.CCR-09-1713
  • Chen Q, Espey MG, Sun AY, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci. 2007;104(21):8749–8754. doi:10.1073/pnas.0702854104
  • Schernhammer E, Wolpin B, Rifai N, et al. Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res. 2007;67(11):5553–5560. doi:10.1158/0008-5472.CAN-06-4463
  • Wei D-H, Mao -Q-Q. Vitamin B6, vitamin B12 and methionine and risk of pancreatic cancer: a meta-analysis. Nutr J. 2020;19(1):1–12. doi:10.1186/s12937-020-00628-7
  • Gong Z, Holly EA, Bracci PM. Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case–control study. Cancer Causes Control. 2009;20(8):1317–1325. doi:10.1007/s10552-009-9352-9
  • Mocellin S, Briarava M, Pilati P. Vitamin B6 and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Institute. 2017;109(3):djw230. doi:10.1093/jnci/djw230
  • Timp W, Bravo HC, McDonald OG, et al. Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors. Genome Med. 2014;6(8):1–11. doi:10.1186/s13073-014-0061-y
  • Olsen GW, Mandel JS, Gibson RW, et al. Nutrients and pancreatic cancer: a population-based case-control study. Cancer Causes Control. 1991;2(5):291–297. doi:10.1007/BF00051668
  • Lin Y, Tamakoshi A, Hayakawa T, et al. Nutritional factors and risk of pancreatic cancer: a population-based case-control study based on direct interview in Japan. J Gastroenterol. 2005;40(3):297–301. doi:10.1007/s00535-004-1537-0
  • Pili R, Salumbides B, Zhao M, et al. Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours. Br J Cancer. 2012;106(1):77–84. doi:10.1038/bjc.2011.527
  • Rosewicz S, Brembeck F, Kaiser A, et al. Differential growth regulation by all-trans retinoic acid is determined by protein kinase C alpha in human pancreatic carcinoma cells. Endocrinology. 1996;137(8):3340–3347. doi:10.1210/endo.137.8.8754760
  • Rosewicz S, Wollbergs K, Von Lampe B, et al. Retinoids inhibit adhesion to laminin in human pancreatic carcinoma cells via the alpha 6 beta 1-integrin receptor. Gastroenterology. 1997;112(2):532–542. doi:10.1053/gast.1997.v112.pm9024307
  • Guan J, Zhang H, Wen Z, et al. Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells. Cancer Lett. 2014;345(1):132–139. doi:10.1016/j.canlet.2013.12.006
  • Bao Y, Ng K, Wolpin B, et al. Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer. 2010;102(9):1422–1427. doi:10.1038/sj.bjc.6605658
  • Skinner HG, Michaud DS, Giovannucci E, et al. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Prev Biomarkers. 2006;15(9):1688–1695. doi:10.1158/1055-9965.EPI-06-0206
  • Zablotska LB, Gong Z, Wang F, et al. Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case–control study in the San Francisco Bay area. Cancer Causes Control. 2011;22(1):91–100. doi:10.1007/s10552-010-9678-3
  • Liu S-L, Zhao Y-P, Dai M-H, et al. Vitamin D status and the risk of pancreatic cancer: a meta-analysis. Chin Med J. 2013;126(17):3356–3359.
  • Pike J, Meyer MB, Bishop KA. Regulation of target gene expression by the vitamin D receptor-an update on mechanisms. Rev Endocr Metab Disord. 2012;13(1):45–55. doi:10.1007/s11154-011-9198-9
  • Persons KS, Eddy VJ, Chadid S, et al. Anti-growth effect of 1, 25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-β-4-ribofuranoside in pancreatic cancer cells. Anticancer Res. 2010;30(6):1875–1880.
  • Robey RB, Hay N. Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis. In: Seminars in Cancer Biology. Elsevier; 2009.
  • Chiang K-C, Chen TC. Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol. 2009;15(27):3349. doi:10.3748/wjg.15.3349
  • Chiang K-C, Yeh C-N, Hsu J-T, et al. The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial–mesenchymal transition in pancreatic cancer cells. Cancer Lett. 2014;354(2):235–244. doi:10.1016/j.canlet.2014.08.019
  • Husain K, Francois RA, Yamauchi T, et al. Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer. Mol Cancer Ther. 2011;10(12):2363–2372. doi:10.1158/1535-7163.MCT-11-0424
  • Shin-Kang S, Ramsauer VP, Lightner J, et al. Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radic Biol Med. 2011;51(6):1164–1174. doi:10.1016/j.freeradbiomed.2011.06.008
  • Hodul PJ, Dong Y, Husain K, et al. Vitamin E δ-tocotrienol induces p27Kip1-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism. PLoS One. 2013;8(2):e52526. doi:10.1371/journal.pone.0052526
  • Greco E, Basso D, Fadi E, et al. Analogs of vitamin E epitomized by α-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. Pancreas. 2010;39(5):662–668. doi:10.1097/MPA.0b013e3181c8b48c
  • Shibayama-Imazu T, Sakairi S, Watanabe A, et al. Vitamin K2 selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol. J Cancer Res Clin Oncol. 2003;129(1):1–11. doi:10.1007/s00432-002-0393-7
  • Wei G, Wang M, Carr BI. Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c‐Jun NH2‐terminal kinase pathways. J Cell Physiol. 2010;224(1):112–119. doi:10.1002/jcp.22099
  • Fan H, Yu Y, Nan H, et al. Associations between intake of calcium, magnesium and phosphorus and risk of pancreatic cancer: a population-based, case–control study in Minnesota. Br J Nutr. 2021;126(10):1549–1557. doi:10.1017/S0007114521000283
  • Kesavan Y, Giovannucci E, Fuchs CS, et al. A prospective study of magnesium and iron intake and pancreatic cancer in men. Am J Epidemiol. 2010;171(2):233–241. doi:10.1093/aje/kwp373
  • Molina‐Montes E, Wark PA, Sánchez MJ, et al. Dietary intake of iron, heme‐iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Int J Cancer. 2012;131(7):E1134–E47. doi:10.1002/ijc.27547
  • Li L, Gai X. The association between dietary zinc intake and risk of pancreatic cancer: a meta-analysis. Biosci Rep. 2017;37(3):114.
  • Alkhatib AJ. Chromium in controlling diabetes and metabolic aspects. Adv Obes Weight Manag Control. 2021;11(3):86–88. doi:10.15406/aowmc.2021.11.00340
  • Kim J, Chung K, Johnson BJ. Chromium acetate stimulates adipogenesis through regulation of gene expression and phosphorylation of adenosine monophosphate-activated protein kinase in bovine intramuscular or subcutaneous adipocytes. Asian Austral J Anim Sci. 2020;33(4):651. doi:10.5713/ajas.19.0089
  • Chen C, Xie Z, Shen Y, et al. The roles of thyroid and thyroid hormone in pancreas: physiology and pathology. Int J Endocrinol. 2018;2018:1–14. doi:10.1155/2018/2861034
  • Thornburg KL, Chattergoon NN. Thyroid hormone and pancreas development: diabetes culprit or innocent bystander? J Physiol. 2017;595(11):3261. doi:10.1113/JP274090
  • Amaral AF, Porta M, Silverman DT, et al. Pancreatic cancer risk and levels of trace elements. Gut. 2012;61(11):1583–1588. doi:10.1136/gutjnl-2011-301086
  • Banim PJ, Luben R, McTaggart A, et al. Dietary antioxidants and the aetiology of pancreatic cancer: a cohort study using data from food diaries and biomarkers. Gut. 2013;62(10):1489–1496. doi:10.1136/gutjnl-2011-301908
  • Burney P, Comstock G, Morris J. Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr. 1989;49(5):895–900. doi:10.1093/ajcn/49.5.895
  • Bosetti C, Turati F, Dal Pont A, et al. The role of Mediterranean diet on the risk of pancreatic cancer. Br J Cancer. 2013;109(5):1360–1366. doi:10.1038/bjc.2013.345
  • Jiao L, Mitrou PN, Reedy J, et al. A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study. Arch Intern Med. 2009;169(8):764–770. doi:10.1001/archinternmed.2009.46
  • Giacosa A, Barale R, Bavaresco L, et al. Cancer prevention in Europe: the Mediterranean diet as a protective choice. Eur J Cancer Prev. 2013;22(1):90–95. doi:10.1097/CEJ.0b013e328354d2d7
  • Molina-Montes E, Sanchez M-J, Buckland G, et al. Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Br J Cancer. 2017;116(6):811–820. doi:10.1038/bjc.2017.14
  • Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: a systematic review and meta‐analysis of observational studies. Int J Cancer. 2014;135(8):1884–1897. doi:10.1002/ijc.28824
  • Schulpen M, Peeters PH, Brandt PA, van den Brandt PA. Mediterranean diet adherence and risk of pancreatic cancer: a pooled analysis of two Dutch cohorts. Int J Cancer. 2019;144(7):1550–1560. doi:10.1002/ijc.31872
  • Bhattacharyya A, Chattopadhyay R, Mitra S, et al. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 2014;94(2):329–354. doi:10.1152/physrev.00040.2012
  • Polvani S, Tarocchi M, Tempesti S, et al. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer. World J Gastroenterol. 2016;22(8):2441. doi:10.3748/wjg.v22.i8.2441
  • Di Gioia F, Tzortzakis N, Rouphael Y, et al. Grown to be blue—Antioxidant properties and health effects of colored vegetables. Part II: leafy, fruit, and other vegetables. Antioxidants. 2020;9(2):97. doi:10.3390/antiox9020097
  • Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, et al. Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer. J Gastrointest Cancer. 2013;44(2):152–161. doi:10.1007/s12029-012-9441-y
  • Sakai M, Kitagawa Y, Saeki H, et al. Fruit and vegetable consumption and risk of esophageal cancer in the Asian region: a systematic review and meta-analysis. Esophagus. 2022;19(1):27–38. doi:10.1007/s10388-021-00882-6
  • Morrison ME, Hobika EG, Joseph JM, et al. Cruciferous vegetable consumption and pancreatic cancer: a case-control study. Cancer Epidemiol. 2021;72:101924. doi:10.1016/j.canep.2021.101924
  • Rees DO, Crick PJ, Jenkins GJ, et al. Comparison of the composition of bile acids in bile of patients with adenocarcinoma of the pancreas and benign disease. J Steroid Biochem Mol Biol. 2017;174:290–295. doi:10.1016/j.jsbmb.2017.10.011
  • Feng H-Y, Chen Y-C. Role of bile acids in carcinogenesis of pancreatic cancer: an old topic with new perspective. World J Gastroenterol. 2016;22(33):7463. doi:10.3748/wjg.v22.i33.7463
  • Gong Z, Huang W, Wang B, et al. Interplay between cyclooxygenase‑2 and microRNAs in cancer. Mol Med Rep. 2021;23(5):1–10. doi:10.3892/mmr.2020.11681
  • Casari I, Falasca M. Diet and pancreatic cancer prevention. Cancers. 2015;7(4):2309–2317. doi:10.3390/cancers7040892
  • Bouvard V, Loomis D, Guyton KZ, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16(16):1599–1600. doi:10.1016/S1470-2045(15)00444-1
  • Ruan Y, Poirier AE, Hebert LA, et al. Estimates of the current and future burden of cancer attributable to red and processed meat consumption in Canada. Prev Med. 2019;122:31–39. doi:10.1016/j.ypmed.2019.03.011
  • Chiang VS-C, Quek S-Y. The relationship of red meat with cancer: effects of thermal processing and related physiological mechanisms. Crit Rev Food Sci Nutr. 2017;57(6):1153–1173. doi:10.1080/10408398.2014.967833
  • Kim Y, Keogh J, Clifton P. A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus. Metabolism. 2015;64(7):768–779. doi:10.1016/j.metabol.2015.03.008
  • Anderson KE, Mongin SJ, Sinha R, et al. Pancreatic cancer risk: associations with meat‐derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Mol Carcinog. 2012;51(1):128–137. doi:10.1002/mc.20794
  • Eichholzer M, Gutzwiller F. Dietary nitrates, nitrites, and N-nitroso compounds and cancer risk: a review of the epidemiologic evidence. Nutr Rev. 1998;56(4):95–105. doi:10.1111/j.1753-4887.1998.tb01721.x
  • Korc M, Jeon CY, Edderkaoui M, et al. Tobacco and alcohol as risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2017;31(5):529–536. doi:10.1016/j.bpg.2017.09.001
  • Oostindjer M, Alexander J, Amdam GV, et al. The role of red and processed meat in colorectal cancer development: a perspective. Meat Sci. 2014;97(4):583–596. doi:10.1016/j.meatsci.2014.02.011
  • Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer. 2011;47(13):1928–1937. doi:10.1016/j.ejca.2011.03.003
  • Koo D-H, Han K-D, Park C-Y. The incremental risk of pancreatic cancer according to fasting glucose levels: nationwide population-based cohort study. J Clin Endocrinol Metab. 2019;104(10):4594–4599. doi:10.1210/jc.2019-00033
  • Li D. Diabetes and pancreatic cancer. Mol Carcinog. 2012;51(1):64–74. doi:10.1002/mc.20771
  • Schernhammer ES, Hu FB, Giovannucci E, et al. Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer Epidemiol Prev Biomarkers. 2005;14(9):2098–2105. doi:10.1158/1055-9965.EPI-05-0059
  • Malik VS, Hu FB. Sweeteners and risk of obesity and type 2 diabetes: the role of sugar-sweetened beverages. Curr Diab Rep. 2012;12(2):195–203. doi:10.1007/s11892-012-0259-6
  • Liu H, Huang D, McArthur DL, et al. Fructose induces transketolase flux to promote pancreatic cancer growth. Cancer Res. 2010;70(15):6368–6376. doi:10.1158/0008-5472.CAN-09-4615
  • Dekker MJ, Su Q, Baker C, et al. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metabol. 2010;299(5):E685–E94. doi:10.1152/ajpendo.00283.2010
  • Kolderup A, Svihus B. Fructose metabolism and relation to atherosclerosis, type 2 diabetes, and obesity. J Nutr Metab. 2015;2015:1–12. doi:10.1155/2015/823081